Every year, the Controlled Release Society (CRS) honors outstanding individuals who have significantly advanced the field of drug release. This year, Prof. Claus-Michael Lehr was honored with the CRS Distinguished Service Award for his many years of commitment to the society and his significant contributions to pharmaceutical science.

InSphero, a global leader in 3D in vitro technology for drug safety and efficacy testing, is partnering with PCRM to offer the 2025 Human Advanced In Vitro Model Initiative (HUMAIN) Award. 

In a campaign launched in April this year, the European Animal Research Association (EARA) justifies the use of dogs in biomedical research and development and argues that this should continue.(1) European animal rights organizations, which are united in the European Coalition to End Animal Experiments (ECEAE), strongly criticize this and refute the arguments.(2)
 

There is an S1 laboratory in the building of the Academy for Animal Welfare Academy of the German Animal Welfare Federation (DTSchB) in Neubiberg near Munich.  The laboratory is to be rented out for use for animal-free (research) projects.

Scientists at the Vienna University of Technology (TU Wien) together with Keio University in Japan have developed a new method for creating blood vessels in tiny organ models on a chip - using ultrashort laser pulses.

On the platform of the Free Association of Student Unions (fzs), students are calling for new animal-free methods to be taught in all relevant study programs right from the start.

In a study, a team of scientists has developed an in vitro model to investigate processes in type 1 diabetes. The model investigates the impairment of human alpha cells by pro-inflammatory cytokines and possible therapeutically effective substances.

The German life science company PL BioScience GmbH, based in Aachen, is specialized in the production and development of human platelet lysate (HPL) for cell expansion. In collaboration with Korean biotech company DewCell Biotherapeutics, PL BioScience has developed a proprietary method to convert lab-grown platelets into a powerful cell culture supplement.

Only until Saturday, May 31, scientists can apply for their innovative scientific work that makes a significant contribution to medical progress based on animal-free, human-based methods for researching and treating human diseases.

Merck KGaA, a leading science and technology company, from Germany, and imec, a world-leading research and innovation center for nanoelectronics and digital technologies, have announced a strategic partnership to develop an advanced platform for microphysiological systems (MPS), also known as organ-on-a-chip systems.